in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (1 week ago)
RT @eNanoMapper: Protégé 5.2.0 released https://t.co/TGg7V4e03v (our tutorial on how to use it for our ontology: https://t.co/Dv00XOzyyB)
Douglas Connect (1 week ago)
RT @barryhardy: Obtain introduction on YouTube to #OpenTox #Garuda #DataAnalysis #2017SOT #ToxExpo @SOToxicology @DouglasConn 2160 https://…
Douglas Connect (3 weeks ago)
Please note that the early-bird/bursary deadlines (31 March) for the #eChemInfo workshop are approaching quickly: https://t.co/NxBAmGIFtz
Douglas Connect (3 weeks ago)
RT @PLOSCompBiol: PathVisio 3: An Extendable Pathway Analysis Toolbox, from Kutmon et al. https://t.co/s4onP5KT2P #SoftwareWednesdays https…
Douglas Connect (3 weeks ago)
RT @ACEnanoH2020: Our website has been officially launched! Check https://t.co/aRNgkYS4GL to be up to date of ACEnano progress. Wish you li…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com